The U.S. Supreme Court has just ruled upon the Amgen v. Connecticut Retirement Plans and Trust Funds case. The securities-fraud case was brought by shareholders that alleged Amgen misled them concerning the dangers of particular drugs that it manufactured. Amgen claims that this information was already well known.
Shareholder derivative suits are often filed when certain investors in a company feel that decisions made by officers or executives will ultimately be detrimental to the firm. Such a lawsuit was recently filed by shareholders for Dell, Inc., a personal computer manufacturer, with regards to a proposed buyout by the founder of the company.
A Connecticut run hedge fund has come under the scrutiny of the Securities Exchange Commission (SEC). Though the hedge fund in question appears to have performed admirably, accusations are being made regarding insider trading and breach of fiduciary duty occurring by at least five employees working for this company.